Pushing for progress with efficient techniquesPotNetwork Holding, Inc. (OTCMKTS:POTN) and its subsidiary, Diamond CBD Inc., remain to be some of the top global distributors of cannabis-based products. As part of their core functions, the companies commit themselves to provide only the purest CBD extracts gathered from cannabis plants through continuous research and development. Through a process called supercritical CO2 extraction, the companies are able to fully isolate CBD from cannabis plants to create the purest oils. The CBD oil gathered is used in the production of top products for Diamond CBD, combined with other ingredients that are all natural, organic and non-GMO. Their selection includes vape liquids, edibles, crystal dabs, and more. PotNetwork and Diamond CBD also continue to reach out to other markets by providing the products that target niche areas. They recently released a pharmacist-formulated line of CBD products called Meds BioTech that caters to the health-conscious. They come in gummies, oil, and capsules, which consumers can take daily to maintain their well-being. By imparting their knowledge and by producing the best products, the leaders are slowly making more people fall in love with the medical aspect of CBD and cannabis. Through their efforts, the global market for cannabis and CBD continue to be on a path toward success, making it one of the industries to watch for. (Featured image via DepositPhotos) —disclaimer for more information. This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
Another biotech gem from Switzerland secures growth capital
A biotech spin-off from the Universities of Zurich and Basel has received new funds from a financing round with renowned...
Industrial espionage costs German companies $229.4 billion
According to the Federation of German Industries (BDI), data theft, industrial espionage and sabotage have cost German companies $229.1 billion...
French Real Estate Crowdfunding grew by 80% in 2019
Real estate crowdfunding is a new way for investors to raise money for their affairs. Crowdfunding for real estate brings...
Growing Capacity: Why Smart Expansion Is Key To Success Among Cannabis Growers
Soaring demand is driving the cannabis market to new highs, as thousands of under served clients can finally obtain their...
Investors react to the Sanofi-Regeneron collaboration
Regeneron Pharmaceuticals Inc shares rebounded as investors found out about collaboration partner Sanofi SA’s liquidation of its Regeneron stake. The...
- Crypto6 days ago
Swiss licensed crypto bank is expanding into 9 new markets
- Business4 days ago
Where Social Media is Headed in 2020
- Biotech7 days ago
Geman Biotech Stocks: Mologen (MGNK) goes insolvent while MorphoSys (MOR) strengthens its position
- Cannabis7 days ago
Brazilian health authority approves registration of cannabis medicines